Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yingyan Han, Zhi Wang, Shujuan Sun, Zeyu Zhang, Jia Liu, Xin Jin, Peng Wu, Teng Ji, Wencheng Ding, Beibei Wang & Qinglei Gao. (2020) Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer. Epigenetics 15:1-2, pages 122-133.
Read now
Read now
Filippa Pettersson, Sonia V del Rincon & Wilson H Miller$suffix/text()$suffix/text(). (2014) Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond. Expert Opinion on Therapeutic Targets 18:9, pages 1035-1048.
Read now
Read now
Articles from other publishers (41)
Shuang Liu, Xinan Qiao, Shuangshuang Wu, Yuqinq Gai, Yongwei Su, Holly Edwards, Yue Wang, Hai Lin, Jeffrey W. Taub, Guan Wang & Yubin Ge. (2022) c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia. Apoptosis 27:11-12, pages 913-928.
Crossref
Crossref
Amandine Badie, Christian Gaiddon & Georg Mellitzer. (2022) Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?. Cancers 14:21, pages 5472.
Crossref
Crossref
Bon-Kwan Koo, Eun-Ji Choi, Eun-Hye Hur, Ju Hyun Moon, Ji Yun Kim, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Eun Kyung Choi, Jinhwan Kim & Je-Hwan Lee. (2022) Antileukemic activity of YPN-005, a CDK7 inhibitor, inducing apoptosis through c-MYC and FLT3 suppression in acute myeloid leukemia. Heliyon 8:10, pages e11004.
Crossref
Crossref
Chansub Lee, Sungyoung Lee, Eunchae Park, Junshik Hong, Dong-Yeop Shin, Ja Min Byun, Hongseok Yun, Youngil Koh & Sung-Soo Yoon. (2022) Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment. Genome Medicine 14:1.
Crossref
Crossref
Michelle Przedborski, David Sharon, Severine Cathelin, Steven Chan & Mohammad Kohandel. (2022) An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia. PLOS Computational Biology 18:9, pages e1010439.
Crossref
Crossref
Huichao Huang, Ying Fu, Yankun Duan, Ye Zhang, Miaolong Lu, Zhuchu Chen, Maoyu Li & Yongheng Chen. (2022) Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells. Frontiers in Genetics 13.
Crossref
Crossref
Matthias Wirth. (2022) Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer. Translational Oncology 17, pages 101343.
Crossref
Crossref
Giulio Donati, Micol Ravà, Marco Filipuzzi, Paola Nicoli, Laura Cassina, Alessandro Verrecchia, Mirko Doni, Simona Rodighiero, Federica Parodi, Alessandra Boletta, Christopher P. Vellano, Joseph R. Marszalek, Giulio F. Draetta & Bruno Amati. (2021) Targeting mitochondrial respiration and the BCL2 family in high‐grade MYC‐associated B‐cell lymphoma. Molecular Oncology 16:5, pages 1132-1152.
Crossref
Crossref
Zhenzhen Li, Huiwen Liu, Ann Bode & Xiangjian Luo. (2021) Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease. European Journal of Pharmacology 898, pages 173972.
Crossref
Crossref
Alessandro Allegra, Roberta Ettari, Vanessa Innao & Alessandra Bitto. (2021) Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma. Cells 10:2, pages 448.
Crossref
Crossref
Xiaowei Wu, Qingyu Luo & Zhihua Liu. (2020) Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options. Cell Death & Disease 11:7.
Crossref
Crossref
Minghua Li, Jing Li, Xiaofang Guo, Hua Pan & Qingyu Zhou. (2020) Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress. Cancers 12:6, pages 1538.
Crossref
Crossref
Viacheslav V. Senichkin, Alena Y. Streletskaia, Anna S. Gorbunova, Boris Zhivotovsky & Gelina S. Kopeina. (2020) Saga of Mcl-1: regulation from transcription to degradation. Cell Death & Differentiation 27:2, pages 405-419.
Crossref
Crossref
Lanqin Wu, Yingying Lin, Jinan Feng, Yuanlin Qi, Xinrui Wang, Qiaofa Lin, Wanyan Shi, Enrun Zheng, Wei Wang, Zhenzhu Hou, Hanbin Lin, Cheng Yu, Yan He, Yan Xu, Hong Yang, Ling Lin & Lisheng Li. (2019) The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein. Cancer Cell International 19:1.
Crossref
Crossref
Mandy Beyer, Annette Romanski, Al-Hassan M. Mustafa, Miriam Pons, Iris Büchler, Anja Vogel, Andrea Pautz, Andreas Sellmer, Günter Schneider, Gesine Bug & Oliver H. Krämer. (2019) HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1. Cancers 11:10, pages 1436.
Crossref
Crossref
Bin‐Bin Li, Bo Wang, Cheng‐Ming Zhu, Di Tang, Jun Pang, Jing Zhao, Chun‐Hui Sun, Miao‐Juan Qiu & Zhi‐Rong Qian. (2019) Cyclin‐dependent kinase 7 inhibitor THZ1 in cancer therapy. Chronic Diseases and Translational Medicine 5:3, pages 155-169.
Crossref
Crossref
Xianxian Ren, Dongdong Cao, Li Yang, Xia Li, Wei Zhang, Yongbiao Xiao, Yu Xi, Feng Li, Dongmei Li & Zemin Pan. (2019) High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China. Scientific Reports 9:1.
Crossref
Crossref
Maki Tanioka, Kevin R. Mott, Daniel P. Hollern, Cheng Fan, David B. Darr & Charles M. Perou. (2018) Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer. Genome Medicine 10:1.
Crossref
Crossref
Nourhan Abdelfattah, Subapriya Rajamanickam, Subbarayalu Panneerdoss, Santosh Timilsina, Pooja Yadav, Benjamin C. Onyeagucha, Michael Garcia, Ratna Vadlamudi, Yidong Chen, Andrew Brenner, Peter Houghton & Manjeet K. Rao. (2018) MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. Nature Communications 9:1.
Crossref
Crossref
Xiaonan Shi, Chunlei Zheng, Ce Li, Kezuo Hou, Xiaoxun Wang, Zichang Yang, Chang Liu, Yunpeng Liu, Xiaofang Che & Xiujuan Qu. (2018) 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation. Cell Biology International 42:1, pages 53-62.
Crossref
Crossref
Kyung-min Lee, Jennifer M. Giltnane, Justin M. Balko, Luis J. Schwarz, Angel L. Guerrero-Zotano, Katherine E. Hutchinson, Mellissa J. Nixon, Mónica V. Estrada, Violeta Sánchez, Melinda E. Sanders, Taekyu Lee, Henry Gómez, Ana Lluch, J. Alejandro Pérez-Fidalgo, Melissa Magdalene Wolf, Gabriela Andrejeva, Jeffrey C. Rathmell, Stephen W. Fesik & Carlos L. Arteaga. (2017) MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. Cell Metabolism 26:4, pages 633-647.e7.
Crossref
Crossref
Khaled Alsayegh, Katsuhisa Matsuura, Hidekazu Sekine & Tatsuya Shimizu. (2017) Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue. Scientific Reports 7:1.
Crossref
Crossref
N Stojanovic, Z Hassan, M Wirth, P Wenzel, M Beyer, C Schäfer, P Brand, A Kroemer, R H Stauber, R M Schmid, A Arlt, A Sellmer, S Mahboobi, R Rad, M Reichert, D Saur, O H Krämer & G Schneider. (2016) HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer. Oncogene 36:13, pages 1804-1815.
Crossref
Crossref
Kaiming Sun, Ruzanna Atoyan, Mylissa A. Borek, Steven Dellarocca, Maria Elena S. Samson, Anna W. Ma, Guang-Xin Xu, Troy Patterson, David P. Tuck, Jaye L. Viner, Ali Fattaey & Jing Wang. (2017) Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers. Molecular Cancer Therapeutics 16:2, pages 285-299.
Crossref
Crossref
Fara Brasó-Maristany, Simone Filosto, Steven Catchpole, Rebecca Marlow, Jelmar Quist, Erika Francesch-Domenech, Darren A Plumb, Leila Zakka, Patrycja Gazinska, Gianmaria Liccardi, Pascal Meier, Albert Gris-Oliver, Maggie Chon U Cheang, Anna Perdrix-Rosell, Manar Shafat, Elodie Noël, Nirmesh Patel, Kristen McEachern, Maurizio Scaltriti, Pau Castel, Farzana Noor, Richard Buus, Sumi Mathew, Johnathan Watkins, Violeta Serra, Pierfrancesco Marra, Anita Grigoriadis & Andrew N Tutt. (2016) PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer. Nature Medicine 22:11, pages 1303-1313.
Crossref
Crossref
Jahangir Abdi, Hou Jian & Hong Chang. (2016) Role of micro-RNAs in drug resistance of multiple myeloma. Oncotarget 7:37, pages 60723-60735.
Crossref
Crossref
Xingchao Zhu, Kaiguang Zhang, Qiaomin Wang, Si Chen, Yawen Gou, Yufang Cui & Qin Li. (2015) Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. Medical Oncology 32:4.
Crossref
Crossref
Ya-Qi Qiu, Cheng-Wei Yang, Yue-Zhi Lee, Ruey-Bing Yang, Chih-Hao Lee, Hsing-Yu Hsu, Chien-Chung Chang & Shiow-Ju Lee. (2014) Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget. Oncotarget 6:4, pages 2148-2163.
Crossref
Crossref
Lixin Yang, Aldwin Apollo Perez, Sayuri Fujie, Charles Warden, Jie Li, Yafan Wang, Bryan Yung, Yun-Ru Chen, Xiyong Liu, Hang Zhang, Shu Zheng, Zheng Liu, David Ann & Yun Yen. (2014) Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer 14:1.
Crossref
Crossref
Tobias Wagner, Peter Brand, Thorsten Heinzel & Oliver H. Krämer. (2014) Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 524-538.
Crossref
Crossref
Lorenzo Colarossi, Lorenzo Memeo, Cristina Colarossi, Eleonora Aiello, Antonio Iuppa, Virginia Espina, Lance Liotta & Claudius Mueller. (2014) Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells. PROTEOMICS - Clinical Applications 8:11-12, pages 924-931.
Crossref
Crossref
Edmond Chipumuro, Eugenio Marco, Camilla L. Christensen, Nicholas Kwiatkowski, Tinghu Zhang, Clark M. Hatheway, Brian J. Abraham, Bandana Sharma, Caleb Yeung, Abigail Altabef, Antonio Perez-Atayde, Kwok-Kin Wong, Guo-Cheng Yuan, Nathanael S. Gray, Richard A. Young & Rani E. George. (2014) CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. Cell 159:5, pages 1126-1139.
Crossref
Crossref
Dong-Qin Chen, Jia-Yuan Huang, Bing Feng, Ban-Zhou Pan, Wei De, Rui Wang & Long-Bang Chen. (2014) Histone Deacetylase 1/Sp1/MicroRNA-200b Signaling Accounts for Maintenance of Cancer Stem-Like Cells in Human Lung Adenocarcinoma. PLoS ONE 9:10, pages e109578.
Crossref
Crossref
Matthias Wirth, Natasa Stojanovic, Jan Christian, Mariel C. Paul, Roland H. Stauber, Roland M. Schmid, Georg Häcker, Oliver H. Krämer, Dieter Saur & Günter Schneider. (2014) MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Nucleic Acids Research 42:16, pages 10433-10447.
Crossref
Crossref
Armen Parsyan & Lorenzo Ferri. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
575
591
.
Seok-Jun Kim, Jung-Ah Hwang, Jae Y. Ro, Yeon-Su Lee & Kyung-Hee Chun. (2013) Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer. Oncotarget 4:9, pages 1461-1471.
Crossref
Crossref
Fabiola Cervantes-Gomez, Lisa S. Chen, Robert Z. Orlowski & Varsha Gandhi. (2013) Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 13, pages S317-S329.
Crossref
Crossref
Laura Conradt, Annika Henrich, Matthias Wirth, Maximilian Reichert, Marina Lesina, Hana Algül, Roland M. Schmid, Oliver H. Krämer, Dieter Saur & Günter Schneider. (2012) Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53‐independent pancreatic cancer cell death. International Journal of Cancer 132:10, pages 2248-2257.
Crossref
Crossref
Sandra Diersch, Patrick Wenzel, Melanie Szameitat, Philipp Eser, Mariel C. Paul, Barbara Seidler, Stefan Eser, Marlena Messer, Maximilian Reichert, Philipp Pagel, Irene Esposito, Roland M. Schmid, Dieter Saur & Günter Schneider. (2013) Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models. Oncotarget 4:2, pages 277-288.
Crossref
Crossref
Columba de la Parra, Elisa Otero-Franqui, Michelle Martinez-Montemayor & Suranganie Dharmawardhane. (2012) The Soy Isoflavone Equol May Increase Cancer Malignancy via Up-regulation of Eukaryotic Protein Synthesis Initiation Factor eIF4G. Journal of Biological Chemistry 287:50, pages 41640-41650.
Crossref
Crossref
Carolin Bier, Shirley K. Knauer, Désirée Wünsch, Lena Kunst, Sabine Scheiding, Markus Kaiser, Christian Ottmann, Oliver H. Krämer & Roland H. Stauber. (2012)
Allosteric inhibition of Taspase1′s pathobiological activity by enforced dimerization
in vivo
. The FASEB Journal 26:8, pages 3421-3429.
Crossref
Crossref